KELSEY PETERSON: Open Payments
NPI 1003393604 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 16 payments from 10 companies in 2025. Trend: 2023 $2,522 · 2024 $374 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $124 |
| Abbott Laboratories | 2 | $43 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $39 |
| Stryker Corporation | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| AtriCure, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: Ozempic, CARDIOMEMS, LifeVest, FLOWTRIEVER, LEQVIO, ATRICLIP LAA EXCLUSION SYSTEM, SYMPLICITY G3, PREVNAR 20.
Industry payments across NE — which companies pay providers there.
